From Decision to Launch, Faster.
Glass-box regulatory and promotional risk intelligence for regulated industries
Competitive Advantage
Strategic Growth AI works with pharma, biotech, AI-health, MedTech, diagnostics, and digital health companies and their agencies to commercialize, scale, and operationalize AI in regulated environments across Canada, the U.S., and the EU.
Our solutions deliver glass-box regulatory and promotional risk intelligence, with transparent, auditable reasoning aligned to emerging AI governance expectations, so teams can move faster without increasing regulatory risk.
When timelines slip, opportunity is lost. We help organizations preserve momentum by clarifying what’s permissible early and governing decisions consistently across execution.
Audit Assurance + Strategic Velocity
We align regulatory strategy, market access, patient support programs (PSPs), and field execution — enabling launches to clear review more efficiently and perform sustainably post-approval.
AI governance is built in, not bolted on.
The Result
✓ Faster, more predictable launches in regulated markets
✓ Real-time adaptation to regulatory and policy change
✓ Trusted, defensible intelligence when decisions are challenged
✓ Reduced manual effort and avoidable errors
✓ More capacity for high-value client and stakeholder engagement
Adapting to regulatory change at speed isn’t optional, it’s your competitive edge.
Why Teams Choose Us
Experienced. Informed. Governed.
-
40+ years across 100+ launches
-
Regulatory-first, designed to stand up to internal, industry, regulator, and payer scrutiny
-
Glass-box, audit-defensible intelligence integrated with existing systems
Our Approach
Decision Clarity First. Execution Second
We work with pharma, biotech, diagnostics, AI-health, MedTech, specialty pharmacies, patient support organizations, regulated companies and their agencies to translate regulatory-informed decisions into consistent, evidence-based execution.
Our approach emphasizes clarity before commitment, traceable rationale over assumptions, and human judgment at every stage, so teams move faster without creating downstream risk.
RegVynt™, OmniVynt™ & DeviceVynt™
How They Work Together
Our solutios deliver glass-box regulatory and promotional risk intelligence, with transparent, auditable reasoning aligned with emerging AI governance expectations in regulated environments.
-
OmniVynt™ sets clear boundaries for permissible messaging before execution.
-
RegVynt™ establishes consistent, defensible review and documentation.
-
DeviceVynt™ maintains alignment between claims, authorization, and real-world use.
Upstream support for regulated decisions, without replacing expert judgment.
🟦 OmniVynt™
Launch Faster in Regulated Markets Without Rework
Primary Users
Marketing, Brand, Commercial Excellence
OmniVynt™ enables commercial and agency teams pre-screen what can be said, and how, using jurisdiction-specific promotional expectations before content is built, briefed, or submitted for medical and legal review. It applies glass-box risk intelligence to commercial decision-making, so teams move faster without creating downstream compliance risk.
What it enables
-
Flags promotional risk early, before it becomes rework
-
Suggests compliant alternatives, not just rejections
-
Reduces agency churn and late-stage escalation
-
Improves first-pass submission quality
-
Accelerates time to market in regulated environments
Outcome:
Cleaner inputs, fewer revisions, and faster, more predictable throughput.
🟩 RegVynt™
Glass-Box Compliance Intelligence
Primary users
Compliance, Medical, Regulatory
Also supports Commercial, Marketing, Market Access, and Operations by reducing rework, improving predictability, and accelerating time to market.
RegVynt™ enables Compliance and Medical teams to operationalize consistent, defensible review across activities, venues, and programs upstream of formal MLR and approval systems.
What it enables
-
Detects repeat-pattern compliance risk early, before issues escalate
-
Improves review consistency and audit defensibility across teams and brands
-
Reduces avoidable revisions and reviewer burden
-
Preserves full human oversight at all times (advisory only, no auto-approval)
Strategic Planning & Risk Review
RegVynt™ extends beyond review into early commercial planning, initiative design, and investment proposals, applying the same glass-box risk intelligence before teams commit resources, budgets, or reputational capital.
Outcome
More consistent, defensible reviews with fewer avoidable revisions, improving efficiency, predictability, and workflow scalability across programs.
🟧 DeviceVynt™
Regulatory and Decision Support for Medical Devices
Primary Users:
Regulatory Affairs, Product Management, Commercial Operations, Sales Enablement
Also supports Marketing and Business Development by reducing rework, preventing unintended claim expansion, and improving submission and review predictability.
DeviceVynt™ helps medical device and medtech teams assess whether product claims, intended use descriptions, and field messaging remain aligned with regulatory classification and approvals before materials and activities are finalized for use in the field.
What it enables
-
Flags claim and intended-use drift early, before it becomes regulatory exposure
-
Identifies implied clinical or diagnostic overreach
-
Aligns sales and marketing language with cleared or approved use
-
Highlights jurisdiction-specific risk (FDA, EU MDR, Health Canada)
-
Reduces late-stage RA intervention and downstream field corrections
Outcome
Clearer alignment of claims to intended use and classification, reducing downstream corrections and supporting predictable execution across device programs.
➡ Explore DeviceVynt™
Intelligence to Execution
Decision Grade Regulatory Intelligence
The Vynt™ modular platform delivers decision-grade regulatory, promotional, and classification-aware intelligence through secure, modular solutions.
Deploy only what you need, where you need it, without fixed architecture or lock-in.
Execution Enablement (Optional)
After decisions are clarified through OmniVynt™, RegVynt™, and DeviceVynt™, we support efficient execution within existing governance.
-
Workflow enablement to reduce manual effort
-
Risk-aware planning for investment and launch decisions
-
Decision documentation for defensible review
-
Extends Vynt solutions; does not replace internal ownership or formal review.
System Integration
Secure integration with existing enterprise systems (e.g., Veeva, Snowflake, EMR, CRM).
Compliance by Design
Audit-ready traceability aligned with privacy and data-governance expectations.
Training & Adoption
Structured onboarding to ensure consistent, correct use.
